Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All drugs

Pemvidutide

Stage Phase 2Stale

Sponsor Altimmune, Inc

Class GLP-1/glucagon

Mechanism GLP-1 and glucagon dual receptor agonist

Sources

registry, as of 2026-07-31Stale

https://clinicaltrials.gov/study/NCT06987513

RECLAIM STUDY: Phase 2 Study of the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or Overweight. Overall status COMPLETED. Phases PHASE2. Lead sponsor Altimmune, Inc.. Enrollment 100. Conditions Alcohol Use Disorder (AUD). This is a Phase 2, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of pemvidutide in the treatment of AUD in subjects with obesity or overweight. After signing the informed consent form, subjects will be screened and if eligible

ClinicalTrials.gov NCT06987513 protocol and results modules

publication, as of 2024-12-18Stale

https://pubmed.ncbi.nlm.nih.gov/39002641/

was a randomized, double-blind, placebo-controlled study to assess the effects of pemvidutide, a glucagon-like peptide-1 (GLP-1)/glucagon dual receptor agonist, on liver fat content (LFC) in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD). Patients with a BMI ≥28.0 kg/m 2 and LFC ≥10%

PMID 39002641

Studies

RECLAIM STUDY: Phase 2 Study of the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or Overweight

Registry NCT06987513

Phase Phase 2

Status Completed

Enrollment 100

Start 2025-05-15

Primary completion 2026-07-30

Study completion 2026-07-30

Catalyst Primary completion. 2026-07-30. ClinicalTrials.gov primary completion date. This is a registry date, not a company readout.Stale

Pemvidutide 2.4 mg

Dose 2.4 mg

Regimen once weekly

Comparator placebo

Population Alcohol Use Disorder (AUD)

Placebo

Regimen once weekly

Population Alcohol Use Disorder (AUD)